Evidence map›Paper›PMID 30669371›Full record

ReviewInternational journal of molecular sciences2019

Ceramide and Regulation of Vascular Tone.

Angel Cogolludo, Eduardo Villamor, Francisco Perez-Vizcaino, Laura Moreno

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 77 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Exploring the effects ofFrontiers in pharmacology · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Sphingolipids: drivers of cardiac fibrosis and atrial fibrillation.Journal of molecular medicine (Berlin, Germany) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Angel CogolludoDepartment of Pharmacology and Toxicology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Ciudad Universitaria S/N, 28040 Madrid, Spain. acogolludo@med.ucm.es.ORCID 0000-0002-1382-1698
Eduardo VillamorDepartment of Pediatrics, Maastricht University Medical Center (MUMC+), School for Oncology and Developmental Biology (GROW), 6202 AZ Maastricht, The Netherlands. e.villamor@mumc.nl.ORCID 0000-0003-1949-9123
Francisco Perez-VizcainoDepartment of Pharmacology and Toxicology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Ciudad Universitaria S/N, 28040 Madrid, Spain. fperez@med.ucm.es.
Laura MorenoDepartment of Pharmacology and Toxicology, School of Medicine, University Complutense of Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Ciudad Universitaria S/N, 28040 Madrid, Spain. lmorenog@med.ucm.es.ORCID 0000-0001-9028-2299
Hospital General Universitario Gregorio Marañón · ESUniversity Medical Center · US

Funding

Instituto de Salud Carlos III PI15/01100Ministerio de Economía y Competitividad SAF2016-77222-R
6 · The paper itself

Abstract

In addition to playing a role as a structural component of cellular membranes, ceramide is now clearly recognized as a bioactive lipid implicated in a variety of physiological functions. This review aims to provide updated information on the role of ceramide in the regulation of vascular tone. Ceramide may induce vasodilator or vasoconstrictor effects by interacting with several signaling pathways in endothelial and smooth muscle cells. There is a clear, albeit complex, interaction between ceramide and redox signaling. In fact, reactive oxygen species (ROS) activate different ceramide generating pathways and, conversely, ceramide is known to increase ROS production. In recent years, ceramide has emerged as a novel key player in oxygen sensing in vascular cells and mediating vascular responses of crucial physiological relevance such as hypoxic pulmonary vasoconstriction (HPV) or normoxic ductus arteriosus constriction. Likewise, a growing body of evidence over the last years suggests that exaggerated production of vascular ceramide may have detrimental effects in a number of pathological processes including cardiovascular and lung diseases.

Indexed as

AnimalsBiomarkersBlood VesselsCeramidesDisease SusceptibilityEndothelium, VascularEnergy MetabolismHumansMechanotransduction, CellularMetabolic Networks and PathwaysOxidation-ReductionOxygenReactive Oxygen SpeciesSignal TransductionVasomotor SystemBiomarkersCeramidesOxygenReactive Oxygen Speciesceramidehypoxic pulmonary vasoconstrictionnormoxic ductus arteriosusoxygen sensingpulmonaryreactive oxygen speciessphingolipidsvascular

Identifiers

PMID30669371
PMCPMC6359388
OpenAlexW2909528388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.